Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 44, Issue 6, 2009, Pages 333-338

  Sparber Sauer, M ^a   Honig M ^a   Schulz, A S ^a   Zur Stadt, U ^b   Schutz C ^a   Debatin, K M ^a   Friedrich, W ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; METHOTREXATE; OKT 3; THIOTEPA; THYMOCYTE ANTIBODY;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RELAPSE; REMISSION; SURVIVOR; VIRUS PNEUMONIA;

CENTRAL NERVOUS SYSTEM DISEASES; CHEDIAK-HIGASHI SYNDROME; CHILD; CHILD, PRESCHOOL; CHIMERISM; DISEASE PROGRESSION; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOPIGMENTATION; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; LYMPHOCYTE DEPLETION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; PREGNANCY; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; SURVIVORS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 70349599414     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.34     Document Type: Article

References (24)

1. Janka G. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166: 95-109.
2. Fischer A, Latour S, de Saint Basile G. Genetic defects affecting lymphocyte cytotoxicity. Curr Opin Immunol 2007; 9: 348-353.
3. Janka G. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-253.
4. Henter JI, Elinder G, Sonder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
5. Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell induces apoptosis. Blood 2002; 100: 2891-2898.
6. Menasche G, Feldmann J, Fischer A, de Sainte Basile G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxity and homeostasis. Immunol Rev 2005; 203: 165-179.
7. Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: Molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 2006; 27: 62-68.
8. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14: 307-311.
9. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25: 173-176.
10. Fischer A, Virelizier JL, Arezana-Seisdedos F, Perez N, Netzelof C, Griscelli C. Treatment of four patients with erythrophagocytis lymphohistiocytosis by a combination of epipodophyllotoxin, steroide, intrathecal methotrexate, and cranial irradiation. Pediatrics 1985; 76: 263-268.
11. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
12. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporine A. Blood 1993; 82: 2319-2323.
13. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
14. Fischer A, Cerf-Bensussan N, Blanche S, Le Deist F, Bremard-Oury C, Leverger G et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986; 108: 267-270.
15. Horne A, Janka G, Egeler RM, Gadner H, Imashuku S, Ladisch S et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622-630.
16. Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood 1997; 89: 3857-3863.
17. Haddad BE, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: Report of 10 cases. Blood 1995; 85: 3328-3333.
18. Henter JI, Samuelsson-Horne AC, Maurizio A, Egeler RM, Elinder G, Filipovich AH et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
19. Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis. A single-center report of 48 patients. Pediatrics 2006; 117: E743-e750.
20. Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM et al. HLA-haploidentical blood progenitor-cell transplantation in osteopetrosis. Blood 2002; 99: 3458-3460.
21. Glucksberg H, Storb R, Fefer A, Buckner C, Neimann P, Clift R et al. Clinical Manifestations of graft-versus-host-disease in human recipients of marrow from HLA-matched donors. Transplantation 1974; 18: 295-304.
22. Shulman H, Sullivan K, Widen P, McDonald G, Striker G, Sale G et al. Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
23. Baker KS, Filipovich AH, Gross TG, Grossmann WJ, Hale GA, Hayashi RJ et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. BMT 2008; 42: 175-180.
24. Dürken M, Hostmann M, Bieling P, Erttmann R, Kabisch H, Löliger C et al. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients. Br J Haematol 1999; 106: 1052-1058.